U.S. Suicide Rate Increased to 14.2 Per 100,000 in 2022
By Elana Gotkine HealthDay Reporter
THURSDAY, Sept. 26, 2024 -- The age-adjusted suicide rate increased in 2021 and 2022, following a decline from 2018 to 2020, reaching 14.2 per 100,000 standard population in 2022, according to a September data brief published by the National Center for Health Statistics.
Matthew F. Garnett, M.P.H., and Sally C. Curtin, from the National Center for Health Statistics in Hyattsville, Maryland, used mortality data from the National Vital Statistics System to present final suicide rates from 2002 through 2022 by sex, age, and means of suicide.
The researchers found that the age-adjusted suicide rate increased between 2002 and 2018, then decreased through 2020 (14.2 to 13.5 deaths per 100,000 standard population in 2018 and 2020, respectively) and increased to 14.1 and 14.2 in 2021 and 2022, respectively. For women aged 25 years and older, declines in suicide rates between 2018 and 2020 were followed by a general increase between 2020 and 2022. Between 2020 and 2022, rates decreased for males aged 10 to 14 and 15 to 24 years and increased in older age groups. In 2022, firearm-related suicide was the leading means of suicide for females (2.0 per 100,000), with rates increasing since 2007, and for males (13.5 per 100,000), with rates increasing since 2006.
"The rate in 2022 (14.2), which was the same as the rate in 2018, marks the highest age-adjusted suicide rate in the United States since 1941," the authors write.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2024-09-27 06:00
Read more
- American College of Allergy, Asthma & Immunology, Oct. 24-28
- Halloween Can Be Extra Scary for Folks With Dementia. An Expert Offers Caregiver Tips
- Weight Loss Meds Help Stroke Survivors Prevent Stroke Recurrence, Death
- Flu Vaccine Coverage 80.7 Percent for Health Workers in Acute Care Hospitals
- Election Fears Are Keeping Americans Awake at Night, Survey Shows
- Knowledge of Abdominal Aortic Calcification Results Improves Some CVD Risk Factors
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions